Schmalzi F, Konwalinka G, Michlmayr G, Abbrederis K, Braunsteiner H
Acta Haematol. 1978;59(1):1-18. doi: 10.1159/000207739.
The present investigations confirm and extend previous reports on the occurrence of cytochemical anomalies among the hemopoietic cells in preleukemia. The cytochemical patterns of the hemopietic cells obtained from 19 patients suffering from a preleukemic disorder have been studied. The diagnostic value of the cytochemical examination using a panel of 10 different tests is emphasized. In a prospective study in 17 out of 25 patients, preleukemia had been correctly diagnosed. In 4 patients leukemia developed within 2-4 months from the diagnosis ('imminent leukemia'), in 13 patients leukemia or smouldering leukemia developed between 4 and 25 months after the diagnosis ('true preleukemia'). The cytochemical profiles of the hemopoietic cells of the latter have been compared with those of 14 patients suffering from aplastic anemia. In preleukemia the blasts did not exceed 3% of the nucleated bone marrow cells. The clinical value of the diagnosis 'preleukemia' is discussed as well as the prognosis and the possible therapeutic approaches.
目前的研究证实并扩展了先前有关白血病前期造血细胞中细胞化学异常情况的报道。对19例患有白血病前期病症患者的造血细胞的细胞化学模式进行了研究。强调了使用一组10种不同检测方法进行细胞化学检查的诊断价值。在一项前瞻性研究中,25例患者中有17例被正确诊断为白血病前期。4例患者在诊断后2至4个月内发展为白血病(“急性白血病”),13例患者在诊断后4至25个月内发展为白血病或隐匿性白血病(“真性白血病前期”)。将后者造血细胞的细胞化学特征与14例再生障碍性贫血患者的细胞化学特征进行了比较。在白血病前期,原始细胞不超过有核骨髓细胞的3%。讨论了“白血病前期”诊断的临床价值以及预后和可能的治疗方法。